nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—hypertension—type 2 diabetes mellitus	0.525	1	CtDrD
Metoprolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0387	0.128	CbGbCtD
Metoprolol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0236	0.0779	CbGbCtD
Metoprolol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0222	0.0732	CbGbCtD
Metoprolol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0211	0.0695	CbGbCtD
Metoprolol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0189	0.0622	CbGbCtD
Metoprolol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0189	0.0622	CbGbCtD
Metoprolol—SLC22A2—Metformin—type 2 diabetes mellitus	0.0178	0.0585	CbGbCtD
Metoprolol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0174	0.0574	CbGbCtD
Metoprolol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0168	0.0555	CbGbCtD
Metoprolol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0152	0.0502	CbGbCtD
Metoprolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0473	CbGbCtD
Metoprolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0132	0.0437	CbGbCtD
Metoprolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0109	0.0359	CbGbCtD
Metoprolol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0105	0.0345	CbGbCtD
Metoprolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0104	0.0344	CbGbCtD
Metoprolol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00967	0.0319	CbGbCtD
Metoprolol—CYP2C19—Losartan—type 2 diabetes mellitus	0.00884	0.0291	CbGbCtD
Metoprolol—ABCB1—Glyburide—type 2 diabetes mellitus	0.0078	0.0257	CbGbCtD
Metoprolol—ABCB1—Losartan—type 2 diabetes mellitus	0.00713	0.0235	CbGbCtD
Metoprolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000529	0.271	CrCbGaD
Metoprolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000455	0.233	CrCbGaD
Metoprolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000248	0.127	CrCbGaD
Metoprolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.0002	0.103	CrCbGaD
Metoprolol—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.000131	0.0674	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.000129	0.066	CrCbGaD
Metoprolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	0.000128	0.0657	CrCbGaD
Metoprolol—Propranolol—CYP1A2—type 2 diabetes mellitus	7.81e-05	0.04	CrCbGaD
Metoprolol—Vomiting—Glimepiride—type 2 diabetes mellitus	6.48e-05	0.000505	CcSEcCtD
Metoprolol—Hypotension—Valsartan—type 2 diabetes mellitus	6.48e-05	0.000505	CcSEcCtD
Metoprolol—Vision blurred—Losartan—type 2 diabetes mellitus	6.47e-05	0.000505	CcSEcCtD
Metoprolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.46e-05	0.000503	CcSEcCtD
Metoprolol—Pain—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000503	CcSEcCtD
Metoprolol—Constipation—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000503	CcSEcCtD
Metoprolol—Rash—Glimepiride—type 2 diabetes mellitus	6.43e-05	0.000501	CcSEcCtD
Metoprolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.42e-05	0.0005	CcSEcCtD
Metoprolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.0005	CcSEcCtD
Metoprolol—Rash—Sitagliptin—type 2 diabetes mellitus	6.4e-05	0.000499	CcSEcCtD
Metoprolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.4e-05	0.000499	CcSEcCtD
Metoprolol—Headache—Glimepiride—type 2 diabetes mellitus	6.38e-05	0.000498	CcSEcCtD
Metoprolol—Headache—Sitagliptin—type 2 diabetes mellitus	6.36e-05	0.000496	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.32e-05	0.000492	CcSEcCtD
Metoprolol—Oedema—Metformin—type 2 diabetes mellitus	6.31e-05	0.000492	CcSEcCtD
Metoprolol—Tinnitus—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000492	CcSEcCtD
Metoprolol—Hypertension—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000491	CcSEcCtD
Metoprolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.29e-05	0.00049	CcSEcCtD
Metoprolol—Insomnia—Valsartan—type 2 diabetes mellitus	6.27e-05	0.000489	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000487	CcSEcCtD
Metoprolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000485	CcSEcCtD
Metoprolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.22e-05	0.000485	CcSEcCtD
Metoprolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000484	CcSEcCtD
Metoprolol—Chest pain—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000484	CcSEcCtD
Metoprolol—Shock—Metformin—type 2 diabetes mellitus	6.21e-05	0.000484	CcSEcCtD
Metoprolol—Insomnia—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000483	CcSEcCtD
Metoprolol—Anxiety—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000483	CcSEcCtD
Metoprolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000483	CcSEcCtD
Metoprolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.19e-05	0.000483	CcSEcCtD
Metoprolol—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.18e-05	0.000482	CcSEcCtD
Metoprolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.18e-05	0.000482	CcSEcCtD
Metoprolol—Vertigo—Losartan—type 2 diabetes mellitus	6.17e-05	0.000481	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000481	CcSEcCtD
Metoprolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.000481	CcSEcCtD
Metoprolol—Somnolence—Valsartan—type 2 diabetes mellitus	6.16e-05	0.00048	CcSEcCtD
Metoprolol—Syncope—Losartan—type 2 diabetes mellitus	6.16e-05	0.00048	CcSEcCtD
Metoprolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.15e-05	0.000479	CcSEcCtD
Metoprolol—Leukopenia—Losartan—type 2 diabetes mellitus	6.15e-05	0.000479	CcSEcCtD
Metoprolol—Skin disorder—Metformin—type 2 diabetes mellitus	6.13e-05	0.000478	CcSEcCtD
Metoprolol—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000476	CcSEcCtD
Metoprolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.1e-05	0.000476	CcSEcCtD
Metoprolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.1e-05	0.000476	CcSEcCtD
Metoprolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000475	CcSEcCtD
Metoprolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.08e-05	0.000474	CcSEcCtD
Metoprolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000474	CcSEcCtD
Metoprolol—Palpitations—Losartan—type 2 diabetes mellitus	6.07e-05	0.000473	CcSEcCtD
Metoprolol—Nausea—Glimepiride—type 2 diabetes mellitus	6.05e-05	0.000472	CcSEcCtD
Metoprolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000471	CcSEcCtD
Metoprolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.04e-05	0.000471	CcSEcCtD
Metoprolol—Nausea—Sitagliptin—type 2 diabetes mellitus	6.03e-05	0.00047	CcSEcCtD
Metoprolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.03e-05	0.00047	CcSEcCtD
Metoprolol—Asthenia—Glyburide—type 2 diabetes mellitus	6.03e-05	0.00047	CcSEcCtD
Metoprolol—Urticaria—Gliclazide—type 2 diabetes mellitus	5.99e-05	0.000467	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.99e-05	0.000467	CcSEcCtD
Metoprolol—Alopecia—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000466	CcSEcCtD
Metoprolol—Fatigue—Valsartan—type 2 diabetes mellitus	5.98e-05	0.000466	CcSEcCtD
Metoprolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.97e-05	0.000465	CcSEcCtD
Metoprolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.97e-05	0.000465	CcSEcCtD
Metoprolol—Oedema—Irbesartan—type 2 diabetes mellitus	5.96e-05	0.000464	CcSEcCtD
Metoprolol—Pruritus—Glyburide—type 2 diabetes mellitus	5.95e-05	0.000463	CcSEcCtD
Metoprolol—Mental disorder—Ramipril—type 2 diabetes mellitus	5.93e-05	0.000462	CcSEcCtD
Metoprolol—Constipation—Valsartan—type 2 diabetes mellitus	5.93e-05	0.000462	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.91e-05	0.000461	CcSEcCtD
Metoprolol—Fatigue—Orlistat—type 2 diabetes mellitus	5.91e-05	0.00046	CcSEcCtD
Metoprolol—Hypotension—Metformin—type 2 diabetes mellitus	5.9e-05	0.00046	CcSEcCtD
Metoprolol—Shock—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000457	CcSEcCtD
Metoprolol—Pain—Orlistat—type 2 diabetes mellitus	5.86e-05	0.000457	CcSEcCtD
Metoprolol—Chest pain—Losartan—type 2 diabetes mellitus	5.85e-05	0.000456	CcSEcCtD
Metoprolol—Arthralgia—Losartan—type 2 diabetes mellitus	5.85e-05	0.000456	CcSEcCtD
Metoprolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.84e-05	0.000456	CcSEcCtD
Metoprolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000455	CcSEcCtD
Metoprolol—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000455	CcSEcCtD
Metoprolol—Anxiety—Losartan—type 2 diabetes mellitus	5.83e-05	0.000454	CcSEcCtD
Metoprolol—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.81e-05	0.000453	CcSEcCtD
Metoprolol—Rash—Bromocriptine—type 2 diabetes mellitus	5.8e-05	0.000452	CcSEcCtD
Metoprolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.79e-05	0.000451	CcSEcCtD
Metoprolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000451	CcSEcCtD
Metoprolol—Tension—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000451	CcSEcCtD
Metoprolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.77e-05	0.00045	CcSEcCtD
Metoprolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000449	CcSEcCtD
Metoprolol—Headache—Bromocriptine—type 2 diabetes mellitus	5.76e-05	0.000449	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.75e-05	0.000448	CcSEcCtD
Metoprolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.75e-05	0.000448	CcSEcCtD
Metoprolol—Nervousness—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000446	CcSEcCtD
Metoprolol—Dry mouth—Losartan—type 2 diabetes mellitus	5.72e-05	0.000446	CcSEcCtD
Metoprolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.67e-05	0.000442	CcSEcCtD
Metoprolol—Paraesthesia—Metformin—type 2 diabetes mellitus	5.67e-05	0.000442	CcSEcCtD
Metoprolol—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000441	CcSEcCtD
Metoprolol—Confusional state—Losartan—type 2 diabetes mellitus	5.65e-05	0.000441	CcSEcCtD
Metoprolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.65e-05	0.00044	CcSEcCtD
Metoprolol—Dyspnoea—Metformin—type 2 diabetes mellitus	5.63e-05	0.000439	CcSEcCtD
Metoprolol—Somnolence—Metformin—type 2 diabetes mellitus	5.61e-05	0.000437	CcSEcCtD
Metoprolol—Oedema—Losartan—type 2 diabetes mellitus	5.61e-05	0.000437	CcSEcCtD
Metoprolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000437	CcSEcCtD
Metoprolol—Hypotension—Irbesartan—type 2 diabetes mellitus	5.57e-05	0.000434	CcSEcCtD
Metoprolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000433	CcSEcCtD
Metoprolol—Dyspepsia—Metformin—type 2 diabetes mellitus	5.56e-05	0.000433	CcSEcCtD
Metoprolol—Shock—Losartan—type 2 diabetes mellitus	5.52e-05	0.00043	CcSEcCtD
Metoprolol—Urticaria—Valsartan—type 2 diabetes mellitus	5.51e-05	0.000429	CcSEcCtD
Metoprolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.5e-05	0.000429	CcSEcCtD
Metoprolol—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.49e-05	0.000428	CcSEcCtD
Metoprolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.48e-05	0.000427	CcSEcCtD
Metoprolol—Tachycardia—Losartan—type 2 diabetes mellitus	5.47e-05	0.000427	CcSEcCtD
Metoprolol—Nausea—Bromocriptine—type 2 diabetes mellitus	5.46e-05	0.000426	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.45e-05	0.000425	CcSEcCtD
Metoprolol—Fatigue—Metformin—type 2 diabetes mellitus	5.44e-05	0.000424	CcSEcCtD
Metoprolol—Urticaria—Orlistat—type 2 diabetes mellitus	5.44e-05	0.000424	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.43e-05	0.000423	CcSEcCtD
Metoprolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.42e-05	0.000423	CcSEcCtD
Metoprolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.42e-05	0.000422	CcSEcCtD
Metoprolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.42e-05	0.000422	CcSEcCtD
Metoprolol—Asthenia—Gliclazide—type 2 diabetes mellitus	5.41e-05	0.000422	CcSEcCtD
Metoprolol—Constipation—Metformin—type 2 diabetes mellitus	5.4e-05	0.000421	CcSEcCtD
Metoprolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000417	CcSEcCtD
Metoprolol—Vomiting—Glyburide—type 2 diabetes mellitus	5.34e-05	0.000416	CcSEcCtD
Metoprolol—Pruritus—Gliclazide—type 2 diabetes mellitus	5.34e-05	0.000416	CcSEcCtD
Metoprolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000414	CcSEcCtD
Metoprolol—Rash—Glyburide—type 2 diabetes mellitus	5.3e-05	0.000413	CcSEcCtD
Metoprolol—Somnolence—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.000413	CcSEcCtD
Metoprolol—Dermatitis—Glyburide—type 2 diabetes mellitus	5.29e-05	0.000413	CcSEcCtD
Metoprolol—Vertigo—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000413	CcSEcCtD
Metoprolol—Syncope—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000412	CcSEcCtD
Metoprolol—Leukopenia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000411	CcSEcCtD
Metoprolol—Headache—Glyburide—type 2 diabetes mellitus	5.26e-05	0.00041	CcSEcCtD
Metoprolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.000409	CcSEcCtD
Metoprolol—Hypotension—Losartan—type 2 diabetes mellitus	5.24e-05	0.000408	CcSEcCtD
Metoprolol—Palpitations—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000406	CcSEcCtD
Metoprolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.2e-05	0.000406	CcSEcCtD
Metoprolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000404	CcSEcCtD
Metoprolol—Propranolol—CYP3A4—type 2 diabetes mellitus	5.17e-05	0.0265	CrCbGaD
Metoprolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.16e-05	0.000402	CcSEcCtD
Metoprolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.16e-05	0.000402	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000401	CcSEcCtD
Metoprolol—Fatigue—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.0004	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.11e-05	0.000398	CcSEcCtD
Metoprolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.11e-05	0.000398	CcSEcCtD
Metoprolol—Pain—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000397	CcSEcCtD
Metoprolol—Constipation—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000397	CcSEcCtD
Metoprolol—Insomnia—Losartan—type 2 diabetes mellitus	5.07e-05	0.000395	CcSEcCtD
Metoprolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.05e-05	0.000393	CcSEcCtD
Metoprolol—Paraesthesia—Losartan—type 2 diabetes mellitus	5.03e-05	0.000392	CcSEcCtD
Metoprolol—Urticaria—Metformin—type 2 diabetes mellitus	5.02e-05	0.000391	CcSEcCtD
Metoprolol—Arthralgia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000391	CcSEcCtD
Metoprolol—Chest pain—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000391	CcSEcCtD
Metoprolol—Dyspnoea—Losartan—type 2 diabetes mellitus	5e-05	0.00039	CcSEcCtD
Metoprolol—Anxiety—Ramipril—type 2 diabetes mellitus	5e-05	0.00039	CcSEcCtD
Metoprolol—Nausea—Glyburide—type 2 diabetes mellitus	4.99e-05	0.000389	CcSEcCtD
Metoprolol—Abdominal pain—Metformin—type 2 diabetes mellitus	4.99e-05	0.000389	CcSEcCtD
Metoprolol—Dizziness—Gliclazide—type 2 diabetes mellitus	4.99e-05	0.000389	CcSEcCtD
Metoprolol—Somnolence—Losartan—type 2 diabetes mellitus	4.98e-05	0.000389	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000388	CcSEcCtD
Metoprolol—Asthenia—Valsartan—type 2 diabetes mellitus	4.97e-05	0.000388	CcSEcCtD
Metoprolol—Dyspepsia—Losartan—type 2 diabetes mellitus	4.94e-05	0.000385	CcSEcCtD
Metoprolol—Asthenia—Orlistat—type 2 diabetes mellitus	4.92e-05	0.000383	CcSEcCtD
Metoprolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.91e-05	0.000383	CcSEcCtD
Metoprolol—Pruritus—Valsartan—type 2 diabetes mellitus	4.91e-05	0.000382	CcSEcCtD
Metoprolol—Dry mouth—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000382	CcSEcCtD
Metoprolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.00038	CcSEcCtD
Metoprolol—Confusional state—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000378	CcSEcCtD
Metoprolol—Pruritus—Orlistat—type 2 diabetes mellitus	4.85e-05	0.000378	CcSEcCtD
Metoprolol—Fatigue—Losartan—type 2 diabetes mellitus	4.83e-05	0.000377	CcSEcCtD
Metoprolol—Oedema—Ramipril—type 2 diabetes mellitus	4.81e-05	0.000375	CcSEcCtD
Metoprolol—Vomiting—Gliclazide—type 2 diabetes mellitus	4.8e-05	0.000374	CcSEcCtD
Metoprolol—Constipation—Losartan—type 2 diabetes mellitus	4.79e-05	0.000374	CcSEcCtD
Metoprolol—Pain—Losartan—type 2 diabetes mellitus	4.79e-05	0.000374	CcSEcCtD
Metoprolol—Rash—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000371	CcSEcCtD
Metoprolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.75e-05	0.000371	CcSEcCtD
Metoprolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.74e-05	0.00037	CcSEcCtD
Metoprolol—Urticaria—Irbesartan—type 2 diabetes mellitus	4.73e-05	0.000369	CcSEcCtD
Metoprolol—Shock—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000369	CcSEcCtD
Metoprolol—Headache—Gliclazide—type 2 diabetes mellitus	4.73e-05	0.000368	CcSEcCtD
Metoprolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000368	CcSEcCtD
Metoprolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000367	CcSEcCtD
Metoprolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.71e-05	0.000367	CcSEcCtD
Metoprolol—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000367	CcSEcCtD
Metoprolol—Tachycardia—Ramipril—type 2 diabetes mellitus	4.69e-05	0.000366	CcSEcCtD
Metoprolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.69e-05	0.000365	CcSEcCtD
Metoprolol—Skin disorder—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000364	CcSEcCtD
Metoprolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000362	CcSEcCtD
Metoprolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.62e-05	0.00036	CcSEcCtD
Metoprolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.59e-05	0.000357	CcSEcCtD
Metoprolol—Dizziness—Valsartan—type 2 diabetes mellitus	4.58e-05	0.000357	CcSEcCtD
Metoprolol—Dizziness—Orlistat—type 2 diabetes mellitus	4.53e-05	0.000353	CcSEcCtD
Metoprolol—Asthenia—Metformin—type 2 diabetes mellitus	4.53e-05	0.000353	CcSEcCtD
Metoprolol—Hypotension—Ramipril—type 2 diabetes mellitus	4.49e-05	0.00035	CcSEcCtD
Metoprolol—Nausea—Gliclazide—type 2 diabetes mellitus	4.48e-05	0.000349	CcSEcCtD
Metoprolol—Pruritus—Metformin—type 2 diabetes mellitus	4.47e-05	0.000348	CcSEcCtD
Metoprolol—Urticaria—Losartan—type 2 diabetes mellitus	4.45e-05	0.000347	CcSEcCtD
Metoprolol—Abdominal pain—Losartan—type 2 diabetes mellitus	4.43e-05	0.000346	CcSEcCtD
Metoprolol—Body temperature increased—Losartan—type 2 diabetes mellitus	4.43e-05	0.000346	CcSEcCtD
Metoprolol—Vomiting—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000344	CcSEcCtD
Metoprolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000342	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000341	CcSEcCtD
Metoprolol—Rash—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000341	CcSEcCtD
Metoprolol—Dermatitis—Valsartan—type 2 diabetes mellitus	4.37e-05	0.00034	CcSEcCtD
Metoprolol—Vomiting—Orlistat—type 2 diabetes mellitus	4.36e-05	0.00034	CcSEcCtD
Metoprolol—Insomnia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000339	CcSEcCtD
Metoprolol—Headache—Valsartan—type 2 diabetes mellitus	4.34e-05	0.000339	CcSEcCtD
Metoprolol—Diarrhoea—Metformin—type 2 diabetes mellitus	4.32e-05	0.000337	CcSEcCtD
Metoprolol—Rash—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000337	CcSEcCtD
Metoprolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000337	CcSEcCtD
Metoprolol—Dermatitis—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000336	CcSEcCtD
Metoprolol—Headache—Orlistat—type 2 diabetes mellitus	4.29e-05	0.000335	CcSEcCtD
Metoprolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000334	CcSEcCtD
Metoprolol—Asthenia—Irbesartan—type 2 diabetes mellitus	4.27e-05	0.000333	CcSEcCtD
Metoprolol—Somnolence—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000333	CcSEcCtD
Metoprolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.23e-05	0.00033	CcSEcCtD
Metoprolol—Pruritus—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000329	CcSEcCtD
Metoprolol—Dizziness—Metformin—type 2 diabetes mellitus	4.17e-05	0.000325	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000324	CcSEcCtD
Metoprolol—Fatigue—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000323	CcSEcCtD
Metoprolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.13e-05	0.000322	CcSEcCtD
Metoprolol—Nausea—Valsartan—type 2 diabetes mellitus	4.12e-05	0.000321	CcSEcCtD
Metoprolol—Constipation—Ramipril—type 2 diabetes mellitus	4.11e-05	0.00032	CcSEcCtD
Metoprolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.000318	CcSEcCtD
Metoprolol—Nausea—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000317	CcSEcCtD
Metoprolol—Asthenia—Losartan—type 2 diabetes mellitus	4.02e-05	0.000314	CcSEcCtD
Metoprolol—Vomiting—Metformin—type 2 diabetes mellitus	4.01e-05	0.000313	CcSEcCtD
Metoprolol—Rash—Metformin—type 2 diabetes mellitus	3.98e-05	0.00031	CcSEcCtD
Metoprolol—Dermatitis—Metformin—type 2 diabetes mellitus	3.98e-05	0.00031	CcSEcCtD
Metoprolol—Pruritus—Losartan—type 2 diabetes mellitus	3.97e-05	0.000309	CcSEcCtD
Metoprolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000309	CcSEcCtD
Metoprolol—Headache—Metformin—type 2 diabetes mellitus	3.96e-05	0.000308	CcSEcCtD
Metoprolol—Dizziness—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000307	CcSEcCtD
Metoprolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000306	CcSEcCtD
Metoprolol—Diarrhoea—Losartan—type 2 diabetes mellitus	3.84e-05	0.000299	CcSEcCtD
Metoprolol—Urticaria—Ramipril—type 2 diabetes mellitus	3.82e-05	0.000298	CcSEcCtD
Metoprolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000296	CcSEcCtD
Metoprolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000296	CcSEcCtD
Metoprolol—Vomiting—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000295	CcSEcCtD
Metoprolol—Rash—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000293	CcSEcCtD
Metoprolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000293	CcSEcCtD
Metoprolol—Nausea—Metformin—type 2 diabetes mellitus	3.75e-05	0.000292	CcSEcCtD
Metoprolol—Headache—Irbesartan—type 2 diabetes mellitus	3.73e-05	0.000291	CcSEcCtD
Metoprolol—Dizziness—Losartan—type 2 diabetes mellitus	3.71e-05	0.000289	CcSEcCtD
Metoprolol—Vomiting—Losartan—type 2 diabetes mellitus	3.57e-05	0.000278	CcSEcCtD
Metoprolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000276	CcSEcCtD
Metoprolol—Nausea—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000276	CcSEcCtD
Metoprolol—Rash—Losartan—type 2 diabetes mellitus	3.54e-05	0.000276	CcSEcCtD
Metoprolol—Dermatitis—Losartan—type 2 diabetes mellitus	3.53e-05	0.000275	CcSEcCtD
Metoprolol—Headache—Losartan—type 2 diabetes mellitus	3.51e-05	0.000274	CcSEcCtD
Metoprolol—Asthenia—Ramipril—type 2 diabetes mellitus	3.45e-05	0.000269	CcSEcCtD
Metoprolol—Pruritus—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000265	CcSEcCtD
Metoprolol—Nausea—Losartan—type 2 diabetes mellitus	3.33e-05	0.00026	CcSEcCtD
Metoprolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000256	CcSEcCtD
Metoprolol—Dizziness—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000248	CcSEcCtD
Metoprolol—Vomiting—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000238	CcSEcCtD
Metoprolol—Rash—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000236	CcSEcCtD
Metoprolol—Dermatitis—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000236	CcSEcCtD
Metoprolol—Headache—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000235	CcSEcCtD
Metoprolol—Nausea—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000223	CcSEcCtD
Metoprolol—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.98e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.97e-06	0.000145	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	5.94e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.89e-06	0.000144	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.89e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.89e-06	0.000143	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	5.88e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.86e-06	0.000143	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5.85e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.84e-06	0.000142	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.84e-06	0.000142	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	5.82e-06	0.000142	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	5.82e-06	0.000142	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.8e-06	0.000141	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	5.8e-06	0.000141	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.78e-06	0.000141	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.76e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	5.76e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.73e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.71e-06	0.000139	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	5.71e-06	0.000139	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.69e-06	0.000139	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.68e-06	0.000138	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.68e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.67e-06	0.000138	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.65e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	5.64e-06	0.000137	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.6e-06	0.000136	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.57e-06	0.000136	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	5.57e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.57e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.54e-06	0.000135	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.5e-06	0.000134	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.48e-06	0.000134	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.47e-06	0.000133	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.46e-06	0.000133	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	5.46e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.43e-06	0.000132	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.4e-06	0.000132	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.35e-06	0.00013	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.35e-06	0.00013	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.34e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.32e-06	0.00013	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	5.29e-06	0.000129	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.25e-06	0.000128	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.24e-06	0.000128	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.22e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.22e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.22e-06	0.000127	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.2e-06	0.000127	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	5.2e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.18e-06	0.000126	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	5.18e-06	0.000126	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	5.12e-06	0.000125	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.1e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.1e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.09e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.09e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.09e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.09e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.03e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.01e-06	0.000122	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.99e-06	0.000122	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.99e-06	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.97e-06	0.000121	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.97e-06	0.000121	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.97e-06	0.000121	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.95e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.9e-06	0.000119	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	4.89e-06	0.000119	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.88e-06	0.000119	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.87e-06	0.000119	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.84e-06	0.000118	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.83e-06	0.000118	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	4.79e-06	0.000117	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.73e-06	0.000115	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.73e-06	0.000115	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.68e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.68e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.68e-06	0.000114	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.67e-06	0.000114	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.65e-06	0.000113	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.65e-06	0.000113	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.65e-06	0.000113	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.6e-06	0.000112	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.6e-06	0.000112	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.59e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.57e-06	0.000111	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.56e-06	0.000111	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.55e-06	0.000111	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.54e-06	0.000111	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	4.51e-06	0.00011	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.5e-06	0.00011	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.49e-06	0.000109	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.49e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.49e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.47e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.46e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.46e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.46e-06	0.000109	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.45e-06	0.000109	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	4.43e-06	0.000108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.41e-06	0.000107	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.41e-06	0.000107	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.4e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.38e-06	0.000107	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.3e-06	0.000105	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.3e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.3e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.28e-06	0.000104	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.23e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.2e-06	0.000102	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.13e-06	0.000101	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.06e-06	9.9e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	4.06e-06	9.89e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.06e-06	9.89e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.06e-06	9.89e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.97e-06	9.69e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	3.89e-06	9.48e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.88e-06	9.46e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	3.88e-06	9.46e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.83e-06	9.33e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	3.81e-06	9.28e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.8e-06	9.26e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.8e-06	9.26e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.78e-06	9.22e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.76e-06	9.17e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.76e-06	9.17e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.74e-06	9.13e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.74e-06	9.13e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.73e-06	9.1e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.71e-06	9.04e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.71e-06	9.04e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.69e-06	9e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.68e-06	8.97e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.68e-06	8.97e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.66e-06	8.93e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.64e-06	8.88e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.62e-06	8.83e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.57e-06	8.71e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	3.55e-06	8.66e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.54e-06	8.62e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.53e-06	8.59e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.5e-06	8.52e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.5e-06	8.52e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.5e-06	8.52e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.48e-06	8.48e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.46e-06	8.43e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.44e-06	8.39e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.43e-06	8.37e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.41e-06	8.32e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.41e-06	8.32e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.39e-06	8.26e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.38e-06	8.23e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.38e-06	8.23e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.34e-06	8.13e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.34e-06	8.13e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.33e-06	8.12e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.31e-06	8.06e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.3e-06	8.03e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.29e-06	8.01e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.25e-06	7.91e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.24e-06	7.9e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.21e-06	7.83e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.21e-06	7.82e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.18e-06	7.76e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.17e-06	7.72e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.14e-06	7.66e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.12e-06	7.59e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.12e-06	7.59e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.11e-06	7.57e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.06e-06	7.45e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.04e-06	7.41e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.02e-06	7.37e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.99e-06	7.28e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.98e-06	7.27e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.96e-06	7.22e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.92e-06	7.13e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.91e-06	7.1e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.9e-06	7.07e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.9e-06	7.06e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.89e-06	7.04e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.88e-06	7.01e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.87e-06	6.99e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.87e-06	6.99e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.86e-06	6.97e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.84e-06	6.93e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.83e-06	6.91e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.83e-06	6.9e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.82e-06	6.86e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.81e-06	6.85e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.8e-06	6.82e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.74e-06	6.67e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.72e-06	6.64e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.71e-06	6.6e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.68e-06	6.53e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.68e-06	6.53e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.67e-06	6.5e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.66e-06	6.47e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.65e-06	6.46e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.64e-06	6.43e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.6e-06	6.33e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.53e-06	6.16e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.52e-06	6.15e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.48e-06	6.04e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.47e-06	6.02e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.47e-06	6.01e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.46e-06	5.99e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.42e-06	5.9e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.4e-06	5.86e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.32e-06	5.66e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.28e-06	5.56e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.27e-06	5.54e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.26e-06	5.5e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.22e-06	5.4e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.21e-06	5.39e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.21e-06	5.38e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.17e-06	5.3e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.17e-06	5.3e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.16e-06	5.27e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.12e-06	5.17e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.12e-06	5.17e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.09e-06	5.09e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2e-06	4.87e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2e-06	4.87e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.99e-06	4.84e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.94e-06	4.73e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.83e-06	4.46e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.78e-06	4.35e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-06	4.14e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.66e-06	4.05e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	3.82e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.53e-06	3.74e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.99e-07	2.43e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.75e-07	2.38e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.19e-07	2.24e-05	CbGpPWpGaD
